SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 188 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $197,595 | -51.1% | 223,019 | -13.3% | 0.00% | – |
| Q3 2022 | $404,000 | +29.1% | 257,319 | +65.1% | 0.00% | – |
| Q2 2022 | $313,000 | -19.5% | 155,819 | -6.6% | 0.00% | – |
| Q1 2022 | $389,000 | -53.5% | 166,825 | -7.2% | 0.00% | -100.0% |
| Q4 2021 | $836,000 | -27.8% | 179,757 | +18.5% | 0.00% | 0.0% |
| Q3 2021 | $1,158,000 | +6.2% | 151,757 | +34.9% | 0.00% | 0.0% |
| Q2 2021 | $1,090,000 | +52.9% | 112,457 | +30.4% | 0.00% | 0.0% |
| Q1 2021 | $713,000 | -4.7% | 86,271 | -21.3% | 0.00% | 0.0% |
| Q4 2020 | $748,000 | -43.1% | 109,635 | -6.9% | 0.00% | -50.0% |
| Q3 2020 | $1,314,000 | -9.8% | 117,820 | -49.2% | 0.00% | 0.0% |
| Q2 2020 | $1,456,000 | +6833.3% | 231,829 | +1960.7% | 0.00% | – |
| Q1 2020 | $21,000 | -75.6% | 11,250 | -29.7% | 0.00% | – |
| Q1 2016 | $86,000 | – | 16,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 15,001 | $1,410 | 0.00% |
| KLCM Advisors, Inc. | 20,000 | $1,880 | 0.00% |
| AlphaMark Advisors, LLC | 3,135 | $0 | 0.00% |
| TRUST CO OF VERMONT | 204 | $19 | 0.00% |
| SlateStone Wealth, LLC | 30,866 | $3 | 0.00% |
| Coppell Advisory Solutions LLC | 100 | $89 | 0.00% |
| Highlander Capital Management, LLC | 1,200 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Russell Investments Group, Ltd. | 266 | $25 | 0.00% |
| OGOREK ANTHONY JOSEPH /NY/ /ADV | 3,600 | $0 | 0.00% |